Author Question: In what portion of the lungs does alveolar dead space normally occur? a. Apexes b. Bases c. ... (Read 63 times)

mynx

  • Hero Member
  • *****
  • Posts: 555
In what portion of the lungs does alveolar dead space normally occur?
 
  a. Apexes
  b. Bases
  c. Middle portions of the lungs
  d. Terminal respiratory units

Question 2

Which is the correct formula to calculate the alveolar minute ventilation of a spontaneously breathing subject?
 
  a. f  VDS/VT
  b. f  VT
  c. f  (VT  VDSphys)
  d. f  (VT + VDSphys)



micaelaswann

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

ANS: A
In the normal upright subject at rest, alveoli at the apexes of the lungs have minimal or no perfu-sion, and thus contribute to the total volume of dead space ventilation.

Answer to Question 2

ANS: C
Physiologic dead space includes both the normal and abnormal components of wasted ventila-tion. VDphy is the preferred clinical measure of ventilation efficiency. Measuring VDphy more accu-rately assesses alveolar ventilation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library